Ashland

AAPS PharmSci 360 brings the pharmaceutical science community to New Orleans from 25 to 28 October 2026. For anyone working...

August, 2026 Commercialization follows strong interest from pharmaceutical developers worldwide Ashland Inc. (NYSE: ASH), has announced the launch of permexa™...

Viatel™ polymers are used in the fabrication of degradable medical devices and tissue engineering solutions. medical devices and tissue engineering...

The promise of oral biologics continues to drive innovation across the pharmaceutical industry.  While permeation enhancement remains critical for successful...

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

Abstract Background/Objectives: Conventional SeDeM-ODT screening relies on physicochemical properties and endpoint disintegration tests, which may have limited discriminatory power among...

Abstract Despite various attempts at solubility enhancement and advances in formulation technologies, improving the bioavailability of poorly water-soluble compounds remains...

Abstract 3D printing has emerged as a novel technology for producing personalized dosage forms tailored to patients’ therapeutic needs. Hot-melt...

Abstract The dynamic and transitory nature of the distal small intestine makes targeted drug delivery to this region particularly challenging....

Abstract This study investigates the performance of different enteric coating systems by integrating dynamic vapor sorption (DVS), optical coherence tomography...